The Monoclonal Antibody Therapy Market is on a trajectory toward unprecedented growth, with projections indicating a market size of USD 232.1 billion by 2035. This significant escalation represents a compound annual growth rate (CAGR) of 3.97% from a current size of USD 151.25 billion in 2024. With increasing investments in biotechnology and personalized medicine, the focus on monoclonal...